 |
Special Report: Brain Imaging Research
Volume 11, Number 5
November/December 1996 |
NIDA's Regional Neuroimaging Center
A new NIDA Regional Neuroimaging Center is employing MRI, PET, and SPECT
in an integrative research strategy for the study of drug addiction. The
Center, at Brookhaven National Laboratory in Upton, New York, is receiving support from NIDA,
the White House Office of National Drug Control Policy, and the U.S. Department
of Energy.
The purpose of the Center is to deepen understanding of the mechanisms of
addiction, develop and test new pharmacological treatments, and create new
imaging tools to advance the understanding and treatment of addiction. One
of the first projects to be tackled is the study of new medications designed to influence how the brain responds
to cocaine, says Dr. Nora Volkow, chairman of the Medical Department and
director of nuclear medicine at Brookhaven. The imaging tools will help
the investigators determine how these new medicines work, for example, as
well as optimum doses and side effects.
Several institutions already working with Brookhaven will participate in
Center investigations. These include Columbia University, Duke University,
various VA hospitals, and others. "This center, with its staff scientists
and collaborating researchers at many institutions, will concentrate the
efforts of many addiction researchers for the purpose of explaining and
influencing the mechanism of addiction in the human brain," says Dr.
Volkow.
From NIDA NOTES, November/December, 1996
[NIDA Home Page][NIDA NOTES Index][1996 Archive Index Index]
|
